CEO Lori Koch attributed the performance to disciplined execution of strategic priorities and robust demand across key markets. The company saw mid-single-digit organic growth in its Healthcare & Water Technologies segment, bolstered by strength in biopharma and personal protection, while the Diversified Industrials segment benefited from ongoing demand in aerospace and electric vehicle applications.
In section Releases
DuPont Raises Full-Year Outlook After Strong Second Quarter
DuPont reported second-quarter 2026 results that surpassed internal guidance, with net sales reaching $1.8 billion, a 4% increase over the previous year. Driven by organic growth and improved productivity, the Wilmington-based company raised its full-year financial projections and announced plans for a $250 million share repurchase program.
Following the second-quarter outperformance, CFO Antonella Franzen increased the midpoint of the company's full-year 2026 operating EBITDA guidance to approximately $1.76 billion. Adjusted earnings per share are now expected to reach $7.24, with organic sales growth projected to climb slightly above 4%. The company also finalized its transition to the Industrials GICS classification effective July 31, 2026, marking a continued shift in its operational focus.
Comments (0)
No comments yet. Be the first!